Paravicini Tamara M, Yogi Alvaro, Mazur Andrzej, Touyz Rhian M
Kidney Research Centre, University of Ottawa/Ottawa Health Research Institute, 451 Smyth Rd, Ottawa, ON, KIH 8M5 Canada.
Hypertension. 2009 Feb;53(2):423-9. doi: 10.1161/HYPERTENSIONAHA.108.124651. Epub 2008 Dec 22.
Inadequate magnesium intake and hypomagnesemia may contribute to chronic diseases, such as hypertension. The novel magnesium transporter TRPM7 is a critical regulator of magnesium homeostasis in vascular cells, but its role in pathophysiology is unclear. In a model of hypomagnesemia, we examined microvascular structure and function, TRPM7 expression, and vascular inflammatory status using inbred mice selected for normal-high intracellular magnesium levels or low intracellular magnesium levels (MgLs). Blood pressure was significantly increased in MgLs compared with normal-high intracellular magnesium levels. Pressurized myography of mesenteric resistance arteries showed that MgLs had significantly impaired endothelial function together with decreased plasma nitrate levels and endothelial NO synthase expression when compared with normal-high intracellular magnesium levels. Significant differences in vascular structure were also evident in both mesenteric arteries and aortas from MgLs. Aortas from MgLs had increased medial cross-sectional areas, whereas mesenteric arteries from MgLs had increased lumen diameters with increased medial cross-sectional areas, indicating outward hypertrophic remodeling. Expression of the magnesium transporter TRPM7 was significantly elevated in the vasculature of MgLs, whereas expression of a TRPM7 downstream target, the anti-inflammatory molecule annexin-1, was reduced. MgLs had increased expression of vascular cell adhesion molecule-1 and plasminogen activator inhibitor-1, indicating vascular inflammation. Taken together, these data demonstrate that the inherited magnesium status of MgLs and normal-high intracellular magnesium levels mice affects magnesium transporter expression, endothelial function, vascular structure, and inflammation. Our findings suggest a potential regulatory role for TRPM7 signaling in the maintenance of vascular integrity. Alterations in magnesium status and/or TRPM7 signaling may contribute to vascular injury in conditions associated with hypomagnesemia.
镁摄入不足和低镁血症可能会导致慢性疾病,如高血压。新型镁转运体TRPM7是血管细胞中镁稳态的关键调节因子,但其在病理生理学中的作用尚不清楚。在低镁血症模型中,我们使用选择具有正常高细胞内镁水平或低细胞内镁水平(MgLs)的近交系小鼠,研究了微血管结构和功能、TRPM7表达以及血管炎症状态。与正常高细胞内镁水平相比,MgLs小鼠的血压显著升高。肠系膜阻力动脉的压力肌电图显示,与正常高细胞内镁水平相比,MgLs小鼠的内皮功能显著受损,同时血浆硝酸盐水平和内皮型一氧化氮合酶表达降低。在MgLs小鼠的肠系膜动脉和主动脉中,血管结构也存在明显差异。MgLs小鼠的主动脉中膜横截面积增加,而MgLs小鼠的肠系膜动脉管腔直径增加,中膜横截面积也增加,表明向外肥厚性重塑。镁转运体TRPM7在MgLs小鼠的脉管系统中表达显著升高,而TRPM7下游靶点抗炎分子膜联蛋白-1的表达则降低。MgLs小鼠血管细胞黏附分子-1和纤溶酶原激活物抑制剂-1的表达增加,表明存在血管炎症。综上所述,这些数据表明,MgLs小鼠和正常高细胞内镁水平小鼠的遗传镁状态会影响镁转运体表达、内皮功能、血管结构和炎症。我们的研究结果表明TRPM7信号在维持血管完整性方面具有潜在的调节作用。镁状态和/或TRPM7信号的改变可能导致与低镁血症相关疾病中的血管损伤。